AL-499: a preliminary evaluation of a new butyrophenone derivative in chronic schizophrenic patients.
D000818:Animals; D002090:Butyrophenones / Q000008:administration & dosage* / Q000627:therapeutic use; D002415:Cats; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*
D002090:Butyrophenones